Professor Wafaa Abdou Zaghary Personal Data

Professor Wafaa Abdou Zaghary

Personal Data

Name Wafaa Abdou Mohamed Abdou Zaghary Gender Female Nationality Egyptian Birth Date 3/ 10/ 1961 Birth Place Cairo, Egypt Present Telephone No. 00238366227 Mobile 00201005233914 00201146449662 Permanent Address 29 Street, Third Neighborhood, Section 4,770/ 771 6th October, Giza, Egypt Current Address 6th October, Giza Email: [email protected] [email protected] Languages: Arabic- English

EDUCATION

22/ 1/ 1994 Ph.D. in Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University. “Synthesis of heterocyclic compounds incorporated to tetralin derivatives of possible pharmacological activity”.

27/ 3/ 1989 MSc. in Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University. “Synthesis of certain pyrimidine derivatives of possible biological activity”.

May/ 1984 Bachelor of Pharmaceutical Sciences (Very Good with Honor), Faculty of Pharmacy, Cairo University.

ACADEMIC POSITIONS

✓ September 28, 2008 Professor of Pharmaceutical Chemistry.

✓ October 10, 2000 Associate Professor of Pharmaceutical Chemistry.

✓ July 21, 1996 Lecturer (Assistant Professor) of Pharmaceutical Chemistry.

✓ March 23, 1994 Researcher (Assistant Professor) of Pharmaceutical Chemistry.

ADMINISTRATIVE POSITIONS at Helwan University (HU), Egypt

EMIC POSITIONS: Date Position Institute

Founder of Pharmaceutical Chemistry Department – College of Pharmacy Helwan University Egypt 1996. 28/9/2008 –till Professor of Pharmaceutical Chemistry Department, College now Pharmaceutical Chemistry of Pharmacy, Helwan University, Egypt 14/ 9/ 2014 – till Professor & head of Pharmaceutical Chemistry Department, Faculty now Pharmaceutical Chemistry of Pharmacy, Helwan University, Egypt Department 29/ 10/ 2000 – Associate Professor of Pharmaceutical Chemistry Department, Faculty 27/ 9/ 2008 Pharmaceutical Chemistry of Pharmacy, Helwan University, Egypt 20/ 12/ 2000-till Associate Professor and Pharmaceutical Chemistry Department, Faculty 16/ 10/ 2005 Acting Head of of Pharmacy, Helwan University, Egypt Pharmaceutical Chemistry Department 21/ 7/ 1996 – 28/ Lecturer of Pharmaceutical Pharmaceutical Chemistry Department, College 10/ 2000 Chemistry of Pharmacy, Helwan University, Egypt

PROFESSIONAL EXPERIENCE ABROAD: SABBATICAL LEAVE and FELLOWSHIPS

Date Position Institute 9/ 2010 – 7/2014 Professor of Pharmaceutical Chemistry Department, Pharmaceutical College of Pharmacy, King Saud University, Chemistry KSA 8/10/2008 – 9/2010 Associate Professor Pharmaceutical Chemistry Department, of Pharmaceutical College of Pharmacy, King Saud University, Chemistry KSA Participant in the establishment of the new Pharmacy College / Female section King Saud University, Riyadh, KSA 2010-2014. 10/ 2005 – 9/ 2008 Associate Professor Pharmaceutical Chemistry Department, and Head of College of Pharmacy Omar Al-Mukhtar Pharmaceutical University, Libya Chemistry Department Founder of Pharmaceutical Chemistry Department – College of Pharmacy Omar Al- Mukhtar University Libya 2005 – 2008. 16/ 10/ 2004 –15/ 12/ Visiting Professor- Chemistry Department, Institute of Pharmacy, 2004 Postdoctoral Fellow Hamburg University, Germany (D.F.G. Grant) 15/ 06/ 1999 –21/ 12/ Visiting Professor Postdoctoral Research - Department of 1999 (Postdoctoral Chemistry Faculty of Arts and Sciences, Fellow) Alabama University U.S.A. 23/ 3/ 1994 – 20/7/ 1996 Researcher Medicinal Chemistry Department, National Research Center, Dokki, Egypt. 6/ 9/ 1989 – 22/ 3/ 1994 Assistant Researcher Medicinal Chemistry Department, National Research Center, Dokki, Egypt

2 3/ 7/ 1989 – 5/ 9/ 1989 Researcher Medicinal Chemistry Department, National Assistance Research Center, Dokki, Egypt 15/ 11/ 1984 – 2/ 7/ Registered Medicinal Chemistry Department, National 1989 Pharmacist Research Center, Dokki, Egypt

RESEARC H PROJECTS Date Title Institute 2020-2021 Nanosized radiopharmaceuticals as Helwan University- Egypt novel solid tumor targeting agents for therapy and/ or imaging 2016-2018 Preparation of laboratory for training Helwan University- Egypt students in the use of accurate analytical devices in the pharmaceutical field. - Code No. (A16/ 7/ 18) - Project fund: 2500000 L.E - PI: Wafaa Zaghary 2016-2018 Nanotechnology Research and Studies Helwan University- Egypt Center - Project fund: 1000000 L.E - Member & representative of Faculty of Pharmacy 2012 – 2014 Synthesis and biological activity of King Saud University, Saudi some novel tetrahydronaphthalene as Arabia antimetabolites. - Grant from the “Research Center of the Center for Female Scientific and Medical Colleges” Deanship of Scientific Research, - Project fund: 40000 SR - CO-PI: Wafaa Zaghary 1995-1998 Study the synthesis of some fused National Research Center, heterocyclic azoles of different Egypt biological activities and their reactions with carbohydrate compounds. - Code No. 3/ 6/ 1/ 2 L - Wafaa Zaghary 1995-1997 Synthesis of heterocyclic compounds as National Research Center, anti- parasitic activity. Egypt - Code No. 3/ 1/ 5B - Wafaa Zaghary 1995-1996 Preparation of N-methyl-P-nitrophenol Academy of Scientific (Intermediate ores) Research and Technology, Egypt

PROFESSIONAL MEMBERSHIP

Faculty of Pharmacy - Helwan University ✓ Member, Faculty Council (2000-2005, 2014-Now). ✓ Chairman, Board of Dept. of Pharmaceutical Chemistry. 2000-2005 & 2014-Now. ✓ Chairman, Committee of Laboratories and Scientific Instruments, HU, 2014-Now. ✓ Chairman, Drug Design Unit, HU, 2014-Now ✓ Member, Cultural Affairs Committee, HU. 2014-2019. ✓ Member Education and Student Affairs Committee, HU. 2014-2019. ✓ Member, Higher Studies and Research, HU. 2014-2019. ✓ Member, Environmental Affairs and Community Service Committee HU, 2014- 2015. ✓ Member, Editorial Board of Advanced Pharmacy Research - Helwan (APRH). 2017- Now. National Research Center ✓ Member of the referee of the scientific committee for promotion of professor and associate professors (Pharmaceutical Chemistry)- National Research Center 2014 – Till now. ✓ Member of Editorial Board of Egyptian Pharmaceutical Journal (EPJ). 2019.

Supreme Council of Universities (SCU) ✓ Member of the referee of the scientific committee for promotion of professor and associate professors (Pharmaceutical Chemistry)- Supreme Council of Universities (SCU), 2016 - 2019. ✓ Member of the scientific committee for promotion of professor and associate professors (Pharmaceutical Chemistry)- Supreme Council of Universities (SCU), 2019 - 2022. ✓ Member of the referee of the scientific committee for promotion of professor and associate professors (Pharmaceutical Chemistry)- Supreme Council of Universities (SCU), 2019 – 2022. Atomic Energy Authority ✓ Member of the referee of the Permanent Scientific Committee for Biological and Medical Sciences to examine the scientific production for the positions of professors and assistant professors 2019.

Faculty of Pharmacy - Zagazig University ✓ Member of the Editorial Board of the Zagazig Journal of Pharmaceutical Sciences (ZJPS) 2019.

Societies and Syndicates ✓ Member of the Egyptian Pharmaceutical Society (Since 1985). ✓ Member of the Saudi Pharmaceutical Society (2008-2014). ✓ Member of Syndicate of Pharmacists (Since 1984). ✓ Member of the Teaching Staff Club of Helwan University (Since1996). ✓ Member of the Egyptian Society of Crystallography.

4 ✓ Member of Society for Women in Science in Developing Countries.

AWARDS/ HONOR

✓ Scientific Excellence Award in Medical Sciences (Helwan University Award for Distinguished Research 2018). ✓ Appreciation Certificate from Dean of College of Pharmacy – King Saud University for obtaining the Canadian counsel for Accreditation of Pharmacy Programs (CCAPP) 26-30/3/2011. ✓ Appreciation Certificate from Dean of College of Pharmacy - Omar Al- Mukhtar University Libya for the establishment of Pharmaceutical Chemistry Department – College of Pharmacy Omar Al-Mukhtar University Libya 2005 – 2008.

SPECIALITY

✓ Medicinal/ Pharmaceutical Chemistry and Drug Design. ✓ Synthesis of new organic molecules for biological evaluation. ✓ Synthesis and biological evaluation of heterocyclic and other agents for radiopharmaceutical diagnosis and treatment. ✓ Modern IR, NMR, Mass, X-ray techniques and application in structure elucidation.

EDUCATIONAL AFFAIRS

A) TEACHING EXPERIENCE

✓ All Standard Medicinal Chemistry courses offered to undergraduate Pharmacy students. Since 1996. ✓ Advanced Medicinal Chemistry courses for graduate students. ✓ Drug Design course for undergraduate and graduate students. ✓ Basic Pharmaceutical Organic Chemistry courses for undergraduate and graduate students. ✓ Stereochemistry in medicinal chemistry for graduate students. ✓ Spectroscopic analysis of organic compounds for graduate students. ✓ Modern Synthetic approaches of bioactive compounds for graduate students. ✓ Medicinal chemistry literature review and seminar in medicinal chemistry for graduate students. ✓ Research techniques in Medicinal Organic Chemistry to new graduate students.

B) EXAMINER of MEDICINAL CHEMISTRY AND DRUG DESIGN COURSES ✓ Internal examiner for Medicinal Chemistry, Drug Design courses and Organic Chemistry, Helwan University. ✓ External examiner for Medicinal Chemistry and Drug Design courses, at different Egyptian Universities: Alexandria, Ain-Shams, Al-Azhar, Cairo, Mansoura, Assuit, Suez-Canal, Tanta, Zagazig, Al-Azhar, 6 October, Misr University of Science and Technology (MUST), Misr International University (MIU), Future University, Modern University for Technology & Information (MTI), Ahram Canadian University and October University of Modern Sciences and Arts.

QUALITY ASSURANCE (QA) in EDUCATION

✓ Internal Auditor of B.Sc. Programs, Faculty of Pharmacy, KSU. 2011 ✓ Internal Auditor of B.Sc. Programs, Faculty of Pharmacy, HU. 2015. ✓ External Auditor of B.Sc. Programs, Faculty of Pharmacy, Assuit University, 2014 - 2019.

SEMINARS, WORKSHOPS and TRAINING COURSES

✓ Attendance of a workshop entitled: roadmap for the establishment of the national science park - Academy of Scientific Research and technology 31 October, 2019. ✓ Chairman of the Organizing Committee of Artificial Intelligence Tools in Drug Design Workshop (Computer-Based Drug Design) for faculty members, staff and students at Pharmaceutical Chemistry Department, Faculty of Pharmacy, Helwan University and different Egyptian Universities 26-27 June, 2019. ✓ Chairman of the Organizing Committee of The 2nd Recent Advances in Drug Discovery Workshop (Computer-Based Drug Design) for faculty members, staff and students at Pharmaceutical Chemistry Department, Faculty of Pharmacy, Helwan University 24-27 June, 2018. ✓ Chairman of the Organizing Committee of The First Drug Design and Discovery Workshop (Computer-Based Drug Design) for faculty members, staff and students at Pharmaceutical Chemistry Department, Faculty of Pharmacy, Helwan University 27-29 August, 2017. ✓ Chairman of the Organizing Committee of LC-MASS Workshop for Faculty members, staff and students at Pharmaceutical Chemistry Department, Faculty of Pharmacy, Helwan University 8-9 March, 2016. ✓ Attendance of different Training Program and seminars at Faculty of Pharmacy, Helwan University 1996-2005. ✓ Computer-based Crystallographic Teaching Materials, Ismailia-Egypt, February 2-7, 2002. ✓ Teaching and educational courses and workshops – Helwan University 1996-2005. ✓ Teaching and educational courses and workshops – King Saud University 2008-2014. ✓ Teaching and educational courses and workshops – Helwan University 2014- now.

RESEARCH and OTHER SCHOLARLY and SCIENTIFIC ACTIVITIES

A) RESEARCH INTEREST

✓ Synthesis and biological evaluation of heterocyclic and other agents for radiopharmaceutical diagnosis and treatment. ✓ Skills of computer-aided drug design. ✓ Application of molecular modeling techniques in development of selective ligands. ✓ Synthesis and structure- elucidation of biologically active products. ✓ Invention of biologically active novel heterocyclic systems. ✓ Medicinal Chemistry of antibacterial, anti-malarial, anticancer, anti-inflammatory agents and other potentially active chemotherapeutic agents. ✓ Interpretation of the binding data and biological activity in terms of Structure Activity Relationship. ✓ Modern IR, NMR, Mass, X-ray techniques and application in structure elucidation. ✓ Different purification techniques and chromatography. ✓ Nanomedicine.

B) SUPERVISION

✓ Supervision of Theses and Dissertations to obtain MSc. and Ph.D. degrees in Medicinal Chemistry, (Since 1994). ✓ Supervision of Review Articles for Post-Graduate Students. HU and KSU (Since 2004). ✓ Supervision of Projects for Undergraduate Pharmacy Students at HU, OMU and KSU (Since 2006)

Scientific Degree Supervisions (Ph.D. & M.Sc.):

No. Student Name Degree University Thesis title Time/ Condition

38 Ola Hassan Ali M. Sc. Helwan Synthesis of biologically active December 2020 peptidomimetics 37 Nosaiba Attia El-Sayed M. Sc. Helwan Design, synthesis and molecular August 2020 Fayadh modeling studies of phenothiazine- based antitumor agents 36 Safaa Alaa Mustafa M. Sc. Helwan Synthesis and biological December 2019 evaluation of newly some developed materials as potential biomedical agents 35 Manar Magdy M. Sc. Helwan Novel 1,8-naphthyridine December, Mohamed Elsayed derivatives: Design, synthesis and 2019 Abuzahara biological evaluation as potential antitumor agents 34 Mohammed Fayed PhD Helwan Design, Synthesis and Biological September, Elsayed Elsabagh Evaluation of New Nano 2019

7 [Atomic Energy Radiopharmaceuticals Authority]

33 Mai Mohamed M. Sc. Helwan Design, Synthesis and Biological October, 2019 Mahmoud Evaluation of Novel Quinoline [Pharmaceutical Derivatives Tagged With Different Chemistry Department] Bioactive Heterocyclic Rings

32 Gehad Kamaleldeen M. Sc. Helwan Synthesis and molecular modeling October, 2019 Hussein Ahmed of new benzimidazloe derivatives [October 6 university] as biologically active compounds

31 Sobhy Moataz M. Sc. Helwan Analysis of Some Antidiabetic March, 2016 [British University] Combination Drugs Using Approved Different analytical techniques January, 2019 30 Mostafa Adel Hassan M. Sc. Helwan Contribution to the Methods of September, 2016 Analysis of Some Oral Approved Antidiabetic Drugs January, 2019 29 Mona Osama PhD Helwan Computational Studies, Synthesis March, 2016 [Atomic Energy and Biological Evaluation of Some Approved Authority] Radiolabeled Triazine Derivatives November, 2018 for Medical Application 28 A’laa Hesham M. Sc. Helwan Design , Synthesis and Molecular November, [Ministry of Health] Modeling Studies of Some Novel 2018 Triazole Derivatives and Related Sulfonamide Hybrids With Predicted Anticancer Activity 27 Dina Nasser M. Sc. Helwan Design, Synthesis, and Molecular October, 2018 [Ministry of Health] Modeling Studies of Some Novel Theinopyrimidinone Derivatives and their Acyclic Nucleosides with Predicted Anticancer Activity 26 Raghda Hassan M. Sc. Helwan Design, Synthesis, and Molecular April, 2018 [Pharmaceutical Modeling and QSAR Studies of Chemistry Department] New Coumarin Derivatives as Cyclin Dependent Kinase Inhibitors of Potential Anticancer Activity 25 Dina Adel PhD Helwan Design, Synthesis and Biological December, 2017 [Pharmaceutical Evaluation of Some Pyrazolo- Chemistry Department Pyrimidine Derivatives Tagged MSA] with Heterocyclic Rings 24 Gihad Ezzat M. Sc. Helwan Design, Synthesis, and Molecular November, 2017 [Ministry of Health] Modeling Studies of Some Novel Benzothiazoles with Expected Potential Anticancer activity 23 Ahmad Mordy M. Sc. Helwan Design, Synthesis and Biological April, 2017 [Pharmaceutical Evaluation of Some Quinazoline Chemistry Department] and Anthranilic Acid Derivatives Tagged with Heterocyclic Rings 22 Rasha El-Amir M. Sc. Helwan Analytical Study on Some February, 2017 [National Organization Antithrombotic drugs for Drug Control and Research NODCAR] 21 Alaa Fahim Mohamed M. Sc. Helwan The Use of Analytical Methods for November, 2016 [National Organization Determination of Some Newly

8 for Drug Control and Approved Antidiabetic Drugs Research NODCAR] 20 Nermeen Abdallah M. Sc. Helwan Analytical Study of Sweeteners as March, 2016 [National Nutrition Food Additives Institute] 19 Marwa AbdelRahman M. Sc. Helwan Analytical Study of Some March, 2016 [National Nutrition Coloring Matters as Food Institute] Additives 18 Reem Ibrahim AL- PhD King Saud Synthesis and Biological Approved 2013 Wabli Evaluation of Some New [Pharmaceutical Quinoline Derivatives and Chemistry Department] Labeling for Detecting Sites of Infections 17 Ayman Bastawy M. Sc. Helwan Synthesis of Some New Approved 2008 Pharmaceutical Antimetabolites of Expected Chemistry Department Chemotherapeutic Effect Ahram Canadian University] 16 Sherifa Mostafa M. Sc. Helwan Uses of Benzoxasines in Synthesis Approved 2007 [Pharmaceutical of Biologically Active Compounds Chemistry Department] 15 Tamer Mostafa M. Sc. Helwan Quality Control of Some Approved 2006 [Atomic Energy Pharmaceutical Preparations Authority 14 Fayrouz Abd El- M. Sc. Helwan Analytical study of some anti- Approved 2006 Hamid inflammatory agents 13 Marwa Frag M. Sc. Helwan Synthesis of Certain Acridine Approved 2006 [Pharmaceutical Derivatives of Anticipated Chemistry Department] Biological Activity

12 Shaimaa Emam M. Sc. Helwan Synthesis of some Glycosides Approved 2006 [Misr International Expected Biological Activity University MIU] 11 Sherif Hmmad M. Sc. Helwan Synthesis and Biological Approved 2005 [Pharmaceutical Evaluation of Some Condensed Chemistry Department] Pyrimidines and Other Heterocyclic Compounds 10 Radwan El-Haggar M. Sc. Helwan Synthesis and In Vitro Evaluation Approved 2004 [Pharmaceutical of Some New Coumarins and Chemistry Department] Related Condense Ring System of Expected Biological Activities 9 Tamer Nasr M. Sc. Helwan Synthesis and Biological Activity Approved 2004 [Pharmaceutical of Some Novel Antimetabolites Chemistry Department] 8 Mohamed Khedr M. Sc. Helwan Preparation of Some Pyrimidine Approved 2004 [Pharmaceutical Derivatives of Expected Biological Chemistry Department] Activities

7 Waleed Ibrahim M. Sc. Helwan Synthesis of certain heterocyclic December, 1998 [Organic Chemistry fenamate derivatives and Approved Department] evaluation of their biological November, 2002 activities 6 Samir Awad M. Sc. Helwan Synthesis of Certain 5- Substituted February, 1998 [Organic Chemistry -2- Thiouracil of Medicinal Approved Department] Interest April, 2002 5 Maha Abou El- M. Sc. Helwan Preparation of Some Heterocyclic Approved 2002

9 Alamin Derivatives of Anticipated [Organic Chemistry Biological Activities Department] 4 Yasser Zohny M. Sc. Helwan Synthesis of Certain Anthracene Approved 2001 [Organic Chemistry Derivatives of Anticipated Department] Antitumor Activity 3 Nesreen Ismail PhD Ain-Shams Synthesis of Some New Nitrogen Approved 2000 [National Research Heterocyclic Compounds of Center] Anticipated Activity 2 Mohamed Abd El- M. Sc. Ain-Shams Synthesis and Characterization of Approved 1998 Motaleb N- Acetanilido Iminodiacetic Acid [Atomic Energy Authority]

1 Marwa El-Kady PhD Cairo Synthesis of Some Tetrahydro- Approved 1998 [National Research acridine Derivatives of Possible Center] Pharmacological Activity

C) AUDITING and REFEREE of SCIENTIFIC ARTICLES in Periodicals, Theses and Dissertations, Promotion Committee, Research Projects, … )

Referee of M.Sc. and Ph.D. Theses and Dissertations ✓ Member of the COMMITTEE-IN-CHARGE for the inspection and refereeing of M.Sc. and Ph.D. Theses in different Egyptian Universities (Helwan, Cairo, Assuit, Mansoura Menoufia, and Zagazig), Egypt. ✓ The inspection and refereeing of M.Sc. and Ph.D. Theses in King Saud University (Pharmacy College and Science College). ✓ The inspection and refereeing of M.Sc. and Ph.D. Theses in different Indian Universities (Acharya Nagarjuna, Andhra) Referee for Promotion Committee Auditing and arbitration of scientific works, introduced for Promotion: ✓ The Scientific Committee for Promotion in Pharmaceutical Chemistry and Biochemistry, SCU, 2016-2019, Egypt. ✓ The Scientific Committee for Promotion of National Research Center (Since 2014). ✓ Ministry of Higher Education / Department of Scientific Affairs / Scientific Promotions. D) Referee of Scientific Projects ✓ Projects introduced to Science and Technology Development Fund (STDF) ✓ Project introduced to King Saud University (KSU).

E) Referee in Periodicals ✓ Auditing and arbitration of scientific articles in the field of pharmaceutical medicinal chemistry and radiopharmaceuticals submitted for publication in globally indexed Journals and Periodicals. Examples: Medicinal Chemistry Research, Journal of European Medicinal Chemistry, Bioorganic Chemistry, Journal of Radioanalytical and Nuclear Chemistry, Molecules, Molecular Imaging & Biology, Journal of Labelled Compounds and Radiopharmaceuticals, Die Pharmazie, Journal of Advanced Pharmacy Research (JAPR), Egyptian Pharmaceutical Journal (EPJ) …etc.

PUBLICATIONS

83. Wafaa A. Zaghary , Nermeen A. Abdallah , Ayman A. Abdelrahim, Marwa A. Zanounb, Emily T. Hanna, Tamer M. Sakr. “ Implementation of nanotechnology in drug analysis as a new solution for old problems: a review”, Egyptian Pharmaceutical Journal 19, 202–215. 2020. 82. Wafaa A Zaghary, Shereen Mowaka, Moataz S Hendy. “Sample Enrichment of Canagliflozin Prior to Its Spectrophotometric Determination in Presence of Metformin: Application to Recently Approved Binary Dosage Form”, Journal of Analytical Chemistry 75 (6), 742-753, 2020. 81. Wafaa A. Zaghary, Ahmed M. Abdalla, Emily T. Hanna, Nermeen A. Shoukry. "Application of multiple reaction monitoring for quantitation of sweeteners in food products", European Journal of Chemistry, 10 (3), 263-266, 2019. 80. Wafaa A. Zaghary, Ahmed M. Abdalla, Emily T. Hanna, Marwa A. T. Zanoun. "Utilization of UPLC-tandem mass spectrometry for quantitation of colouring

matters in dietary formulation", European Journal of Chemistry, 10 (3), 239-243,

2019. 79. Esraa A Abdelsalam, Wafaa A Zaghary, Kamilia M Amin, Nageh A Abou Taleb, Amal AI Mekawey, Wagdy M Eldehna, Hatem A Abdel-Aziz, Sherif F Hammad. "Synthesis and in vitro anticancer evaluation of some fused indazoles, quinazolines and quinolines as potential EGFR inhibitors", Bioorganic Chemistry, 90, 102985, 2019. 78. WA Zaghary, S Mowaka, MS Hendy. "Summary of chromatographic analysis Methods of anti-diabetic Gliflozins Empagliflozin, Canagliflozin and Dapa- gliflozin", Indian Drugs, 56 (7), 80-83, 2019. 77. WA Zaghary, Emily T. Hanna, Marwa A. Zanoun, Nermeen A. Abdallah, Tamer M. Sakr. "Curcumin: Analysis and Stability", Journal of Advanced Pharmacy Research, 3 (1), 47-58, 2019. 76. Wafaa A Zaghary, Shereen Mowaka, Moataz S Hendy. "Kinetic Degradation Study of Dapagliflozin Coupled with UHPLC Separation in the Presence of Major Degradation Product and Metformin", Chromatographia, 82, (4), 777-789, 2019. 75. Mohammed A Khedr, Reem I Al-Wabli, Maha S Almutairi, Wafaa A Zaghary. "QSAR-based rational discovery of novel substituted-4′-iminospiro [indoline-3, 3′- [1, 2, 5] thiadiazolidinyl]-2-one-1′, 1′-dioxide with potent in vitro anticancer Activity", BMC Chemistry, 13 (1), 3, 2019. 74. M. A. Motaleb, I. T. Ibrahim, M. O. Sarhan, W. A. Zaghary. "Radioiodination and biological distribution of a new s-triazine derivative for tumor uptake evaluation". Journal of Labelled Compounds and Radiopharmaceuticals, DOI: 10.1002/jlcr.3682; 1– 1 August; 61(14), 1058-1068, 2018. 73. WA Zaghary, MA Motaleb, IT Ibrahim, MO Sarhan. "Preparation, Biodistribution of 99mTc-Azacytidine Complex as a Potential Agent for Radiotherapy", Journal of Advanced Pharmacy Research, 2 (1), 62-73, 2018.

11 72. Shereen Mowaka , Bassam M. Ayoub, Mostafa A. Hassan, Wafaa A. Zaghary. "Different Spectrophotometric Methods for Simultaneous Determination of Trelagliptin and its Acid Degradation Product". Journal of Analytical Methods in Chemistry, https://doi.org/10.1155/2018/7370651 2018. 71. MO Sarhan, MA Motaleb, IT Ibrahim, MM Anwar, WA Zaghary. "Development, Potential Anticancer Activity and the Receptor Profile of Different Functionalized 1,3,5-Triazine Derivatives". Mini Reviews in Medicinal Chemistry, 18 (15), DOI: 10.2174/1389557517666170927160256, 2018. 70. Wafaa A. Zaghary, Shereen Mowaka , Mostafa A. Hassan, Bassam M. Ayoub. "Suitability of various chromatographic and spectroscopic technique for analysis And kinetic degradation study of trelagliptin", Scientific Reports| 7: 17255 DOI:10.1038/s41598-017-17642-1, Published: 8 December 2017. 69. Wafaa A Zaghary, Shereen Mowaka, Moataz S Hendy. "Comparative Liquid Chromatographic Study for Concurrent Determination of Canagliflozin and Metformin in Combined Tablets", Journal of Analytical Methods in Chemistry, https://doi.org/10.1155/2017/9197230 2017 68. Tamer Nasr, Samir Bondock, Mahmoud Youns, Walid Fayad, Wafaa Zaghary. "Synthesis, antitumor evaluation and microarray study of some new pyrazolo-[3,4- d][1,2,3]triazine derivatives", European Journal of Medicinal Chemistry, 141, 603- 614, 2017. 67. Mohammed Y Ebied, Wafaa A Zaghary, Kamelia M Amin, Sherif F Hammad. "Synthesis and Antimicrobial Evaluation of Some Tricyclic Substituted Benzo-[h] quinazolines, Benzo [h]quinolines and Naphthaleno [d] thiazoles", Journal of Advanced Pharmacy Research ISSN: 2357-0539 (Online, October), 1 (4), 216-227, 2017 66. Wafaa A. Zaghary, Shereen Mowaka , Mostafa A. Hassan, Bassam M. Ayoub. "Comparative study between different simple methodsmanipulating ratio spectra for the analysis of alogliptin and metformin co-formulated with highly different concentrations", Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy186, 23-28, 2017. 65. Galal Elgemeie, Nahed Fathy, Wafaa Zaghary & Ayman Farag. "S-Glycosides in Medicinal Chemistry: Novel Synthesis of Cyanoethylene Thioglycosides and Their Pyrazole Derivatives", Nucleosides, Nucleotides and Nucleic Acids, 36 (3), 198-212 2017. DOI: 10.1080/15257770. 2016.1257807. 64. MM Kamel, WA Zaghary, RI Al-Wabli, MM Anwar. "Synthetic approaches and potential bioactivity of different functionalized quinazoline and quinazolinone scaffolds", Egyptian Pharmaceutical Journal, 15 (3), 98-131, 2016. 63. Reem Ibrahim Al‑Wabli, Tamer Mostafa Mohamed Hafez Sakr, Mohammed Abdou Khedr, Adly Abdallah Selim, Mohamed Abd El‑Motaleb Abd El‑Rahman and Wafaa Abdou Zaghary. "Platelet‑12 lipoxygenase targeting via a newly synthesized curcumin derivative radiolabeled with technetium‑99m", Chemistry Central Journal, 10:73, 2016, DOI 10.1186/s13065-016-0220-x 62. Mohsen M. Kamel, Kamelia M. Amin, Wafaa A. Zaghary, Nageh A. Abou Taleb and Marwa F. Ahmed. Synthesis, Anyimicrobial, "Evaluation and Molecula Docking of

12 Some Pyridine, Pyran, Pyrazoline and/ or Isoxazoline-9-(p-Subustitutedanilino)- Acridine Derivatives", International Journal of Innovative Drug Discovery, 6 (2),) 101-110, 2016. 61. Tamer Nasr, Mahmoud Youns, Samir Bondock, Wafaa Zaghary. "Synthesis and Biological evaluation of new pyrazolotriazinone derivatives as antitumor agents", 6th International Chemistry Conference 2016: 8th to 10th November at King Saud University, Riyadh, Saudi Arabia. 60. Wafaa A. Zaghary, Mohammed A. Motaleb, Manal M. Anwar. "Preliminary assessment of 99mTc-salmeterol xinafoate as a potential bone-imaging agent", The Open Conference Proceedings Journal, 7, 1-8, 2016. 59. Eman M. Flefel, Hebat-Allah S. Abbas , Randa E. Abdel Mageid and Wafaa A. Zaghary, "Synthesis and Cytotoxic Effect of Some Novel 1,2-Dihydropyridin-3- carbonitrile and Nicotinonitrile Derivatives", Molecules, 21, 30, 2016. 58. Wafaa A. Zaghary, Mohammed A. Motaleb, Manal M. Anwar. "Preliminary assessment of 99mTc-salmeterol xinafoate as a potential bone-imaging agent", Drug Discovery and Therapy World Congress 2015: 22nd to 25th July 2015 at John B. Hynes Veterans Memorial Convention Center, Boston, USA. 57. Mohammed A. Khedr and Wafaa A. Zaghary, "Discovery of Novel Potential Hypoglycemic agents by a Structure-Based Design Approach", 3rd Future University International Conference on Pharmaceutical Sciences, February 9-11, 2015 at Intercontinental City Stars Hotel, Nasr City, Cairo, Egypt. (Poster presentation). 56. Manal M. Anwar, Radwan S. El-Haggar, Wafaa A. Zaghary. "Salmeterol Xinafoat", In Harry Brittain, editor: Profiles of Drug Substances, Excipients, and Related Methodology Vol 40, PODRM, UK: Academic Press, 2015, pp. 321-369. Available online, 1 April 2015. 55. Maha S. Al Mutairi, Mohammed A. Motaleb, Nadia G. Haress, Wafaa A. Zaghary. "Biodistribution of 99mTc–2-aminoestrone-3-methyl ether as a potential radiotracer for inflammation imaging", Journal of Radioanalytical and Nuclear Chemistry, 303, 237-244, Journal of Radioanalytical and Nuclear Chemistry, 303: 237-244, 2015. 54. T. M. Sakr, M. A. Motaleb, W. A. Zaghary. "Synthesis, radioiodination and in vivo evaluation of ethyl 1,4-dihydro-7-iodo-4-oxoquinoline-3-carboxylate as a potential pulmonary perfusion scintigraphic radiopharmaceutical", Journal of Radio- analytical and Nuclear Chemistry, 303: 399-406, 2015. 53. Maha S. Al Mutairi, Mohammed A. Motaleb, Nadia G. Haress and Wafaa A. Zaghary. "Biodistribution of 99mTc-2-Aminoestrone-3-Methyl Ether as a Potential Radiotrace Inflammation Imaging", Metabolomics & Systems Biology Conference. 24-26 March 2014. San Antonio, USA. 52. Reem I. Al-wabli, Mohammed A. Khedr, Rabab El Dib, Nadia G. Haress, and Wafaa A.Zaghary. "3-substituted-4-Quinolines: effect of substituents on NMR Features and the Relationship Between, Molecular Docking and Antibacterial Activity", Drug Discovery & Therapy World Congress June, 16-19 2014, Boston, MA, USA. 51. Reem I. Al-wabli, Mohammed A. Khedr, Adnan A. Kadi, Mohammed A. Motaleb, Khalid A. Al-rashood, and Wafaa A. Zaghary. "Synthesis, molecular docking and antibacterial evaluation of various quinoline schiff bases: labeling and

13 biodistribution of 99mTc-2-(p-hydroxybenzylidene)-1-(quinolin-4-yl) hydrazine", 6Th International Conference on Drug Discovery & Therapy February 10th – 12th, 2014, Dubai, UAE. 50. Samir Bondock, Tamer Nasr, Wafaa Zaghary, Suchada Chantrapromma, Hazem Ghabbour, Hoong-Kun Fun, "Diastereoselective Synthesis and X-ray Crystallographic Studies of new (E)-2-cyano-N-(4-ethoxyphenyl)-3-methylthio-3- (substituted-amino)acrylamides", Molecular Crystal and Liquid Crystal, 605: 165– 178, 2014. 49. Reem I. Al-wabli, Mohammed A. Khedr, Adnan A. Kadi, Mohammed A. Motaleb, Khalid A. Al-rashood, and Wafaa A. Zaghary. "Synthesis, molecular docking and antibacterial evaluation of various quinoline schiff bases: labeling and biodistribution of 99mTc-2-(p-hydroxybenzylidene)-1-(quinolin-4-yl) hydrazine", Med. Chem. Res. 23: 4011–4020, 2014. Available online: 11 March 2014. 48. M. A. Motaleb, N. M. Al-Musayeib, E. S. Al-abdullah, H. A. Shweeta, W. A. Zaghary."Synthesis and evaluation of a novel 99mTc-shikonin as a potential tumor imaging agent and in-vitro antitumor activity of shikonin dioxime", 34th EORTC- PAMM-BACR meeting, Cardiff Wales, UK. 23-26 January 2013. 47. Maha S. Al-Mutairi, Ebtehal S. Al-Abdullah, Mogedda E. Haiba, Mohammed A. Khedr and Wafaa A. Zaghary. "Synthesis, Molecular Docking and Preliminary in-Vitro Cytotoxic Evaluation of Some Substituted Tetrahydronaphthalene (2',3',4',6'- Tetra-O-Acetyl-β-D-Gluco-/Galactopyranosyl) Derivatives", Molecules, 17: 4017– 4730, 2012. 46. M. A. Motaleb, N. M. Al-Musayeib, W. A. Zaghary, H. A. Shweeta. "Synthesis and preclinical pharmacological evaluation of a novel 99mTc–shikonin as a potential tumor imaging agent", Journal of Radioanalytical and Nuclear Chemistry, 293: 391- 396, 2012. 45. Wafaa A. Zaghary, Reem I. Al-Wabli and Seik Weng Ng. "3-Ethoxymethyl-1,4- dihydroquinolin-4-one", Acta crystallographica. Section E, Structure reports, E68, o2234 2012. [doi:10.1107/S1600536812028383] 44. Wafaa A. Zaghary, Detlef Geffken and Seik Weng Ng. "6-Amino-4-(3-iodo•anilino)- 2-methyl•pyrimidin-1-ium chloride", Acta crystallographica. Section E, Structure reports, E68, o2235 2012. [doi:10.1107/S1600536812028401] 43. Reem I. Al-wabli, M. A. Motaleb, Adnan A. Kadi , Khalid A. Al-rashood, Wafaa A. Zaghary. "Labeling and biodistribution of 99mTc-7-bromo-1,4-dihydro-4-oxo- quinolin-3- carboxylic acid complex", Journal of Radioanalytical and Nuclear Chemistry, 290: 507-513, 2011. 42. M. A. Motaleb, E. S. Alabdullah, W. A. Zaghary. "Synthesis, Radiochemical and Biological Characteristics of 99mTc-Quinoline Derivative Complex: A Novel Agent for Infection Imaging ", Journal of Radioanalytical and Nuclear Chemistry, 287: 61- 67, 2010. 41. Galal H. Elgemeie, Wafaa A. Zaghary, Kamelia M. Amin, and Tamer Nasr. "First Synthesis of Thiophene Thioglycoside", Journal of Carbohydrate Chemistry, 28: 161- 178, 2009. 40. W. A. Zaghary and A. A. E. Ahmed. "N-Galloylhydroxylamine From Penta galloyl-

14 glucose: Analgesic and Anti-inflammatory Activities, Semi-synthesis", Egypt. Pharm. J., 7: 105-113, 2008. 39. Galal H. Elgemeie, Wafaa A. Zaghary, Tamer Nasr, and Kamelia M. Amine, "First Synthesis of Thienopyrazole Thioglycosides", Journal of Carbohydrate Chemistry, 27: 345-356, 2008. 38. Galal H. Elgemeie, Wafaa A. Zaghary, Kamelia M. Amin, and Tamer Nasr, "A Direct Route to a New Class of Acrylamide Thioglycosides", Journal of Carbohydrate Chemistry, 27: 373-378, 2008. 37. W. A. Zaghary. "Labeling and biodistribution of 99mTc-4- hydroy -7- fluoroquinoline-3-carboxylic acid complex", Arab Journal of Sciences and Application, 41: (2) 71 – 79, 2008. 36. Wafaa A. Zaghary. "Synthesis of some tetrahydronaphthalene derivatives of expected analgesic and anti-inflammatory activities", Bull. Fac. Pharm. Cairo Univ., 45: 391-400, 2007. 35. R. I. El-Bagary, A. A. El-Zaher, F. A. Soliman and W. A. Zaghary. "Spectrophotometric, fluoromertric and high performance liquid chromatographic methods for determination of celecoxib", Bull. Fac. Pharm.Cairo Univ. 45: (2) 109- 118, 2007. 34. M. M. Kamel, Z. Nofal, W. A. Zaghary, M. Refai, N. Ismael. "Synthesis of some new 4-(p-heterocyclosubstituted anilino)-2,7-dimethyl-1,8-naphthyridine of expected antimicrobial activity", Egypt. J. Chem. 50: (3) 36-390, 2007. 33. M. Y. Ebeid, M. M. Kamel, Z. M. Nofal, F. Ragab, W. A. Zaghary and M. El Kady "New antimicrobial 9-(p-Heteroyclo-substituted aniline -)tetrahydroacridines", Egypt. J. Chem., 49: (2) 277-285, 2006. 32. Galal H. Elgemeie, Wafaa A. Zaghary, Kamelia M. Amin, Tamer Nasr. "New Trends in Synthesis of Pyrazole Nucleosides as New Antimetabolites", Nucleosides, Nucleotides, and Nucleic Acids, 24: (8) 1227–1247, 2005. 31. W. A. Zaghary, A. A. El-Azzouny, M. A. Motaleb and M. A. Khedr. "Synthesis of Some Pyrimidine Derivatives of Expected Biological Activities". Bull. Pharm. Sci., Assiut University, 28: 1, 17-25 2005. 30. W. A. Zaghary, M. E. Haiba, M. M. Anwar and S. A. Hassan. "Synthesis and in vitro anticancer evaluation of some new (tetrahydronaphthalen-2-yl) nitrogen heterocycles", Egypt. Pharm. J., 4: (1) 145-156, 2005. 29. K. M. Amin, W. A. Zaghary and R. S. El-Haggar. "Synthesis of in vitro evaluation of some new coumarins and related condensed ring systems of expected antimicrobial activity", Egypt. Pharm. J., 4: (2) 413-437, 2005. 28. M. A. Hassanein, A. A. El-Mohty, W. A. Zaghary and T. M. Saker "Production of carrier-free radioactive copper from neutron irradiated zinc targets", Isotope & Rad. Res., 37: (1) 236 -272, 2005. 27. Aida A. El-Azzouny, Yousreya A. Maklad, Herbert Bartsch, Wafaa A. Zaghary, Waleed M. Ibrahim, and Mosaad S. Mohamed. "Synthesis and Pharmacological Evaluation of Fenamate Analogues: 1,3,4-Oxadiazol-2-ones and 1,3,4- Oxadiazole- 2-thiones", Scientia Pharmaceutica, 71: 331-356, 2003. 26. M. M. Kamel, E. M. Mohi El-Deen and W. A. Zaghary. "New tetracyclic compounds including thieno[2,3-b:4,5-b]dipyridine of possible antimicrobial activity", Bull.

15 Fac. Pharm. Cairo Univ., 41: (1) 197-205, 2003. 25. O. A. Fathalla, W. A. Zaghary, E. M. M. Kassem, Y. M. Zohny and M. S. Mohamed "Synthesis of certain anthracene derivatives of anticipated antitumor activity", Bull. Fac. Pharm. Cairo Univ., 40: 185-192, 2002. 24. M. S. Mohamed, W. A. Zaghary, T. S. Hafez,, Nabila Ibrahim, M. M. Abo El-Alamin and M. R. Mahran. "Reaction with certain 4-hydroxycoumarine derivatives", Bull. Fac. Pharm. Cairo Univ. 40: 175-184, 2002. 23. O. A. Fathalla, W. A. Zaghary, H. H. Radwan, S. M. Awad and M. S. Mohamed "Synthesis of some new 2- thiouracil-5-sulfonamide derivatives with expected biological activity", Archives of Pharmacal Research, 25: 258-269, 2002. 22. M. Y. Ebeid, M. M. Kamel, F. Ragab, Z. M. Nofal, A. A. E. Ahmed, W. A. Zaghary and M. El Kady. "New 9-(p-substituted aniline)-tetrahydroacridine as acetylcholine estrase inhibitors", A. Z. J. Pharm. Sci., 24: 114-132, 1999. 21. W. A. Zaghary. "Synthesis of some new 1,2,3,4-tetrahydronaphthalene derivatives of possible biological activity", A. Z. J. Pharm. Sci., 24: 51-61, 1999. 20. E. A. El- Ghany, W. A. Zaghary, M. A. Motaleb, M. Raieh and M. M. Abdalla. "Synthesis and labelling of some halogenated derivatives of N-acetanilido- iminodiacetic acid with Technetium-99m", Arab Journal of Sciences and Application, 32: (1) 59 – 74 1999. 19. E. A. El- Ghany, W. A. Zaghary, A. A. El-Mohty, M. T. El-Kolaly, M. Raieh and A.A. El-Bary. "Organic synthesis and direct labeling of benzoyl protected mercapto- acetyl triglycine ( S-Bz-MAG3 ) with technetium- 99m as tubular function agent", Arab Journal of Sciences and Application, 31: (1) 99 – 108, 1998. 18. E. A. El- Ghany, A. A. El-Mohty, W. A. Zaghary, M. T. El-Kolaly, M. Raieh and A.A. El-Bary. "Synthesis, characterization and evaluation of 99mTc-L, L-ethylene- cysteine dimmer to assess regional cerebral blood flow", Journal of Radioanalytical and Nuclear Chemistry, 232: (1-2) 223 – 228, 1998. 17. M. M. Kamel, O. A. Fathalla, W. A. M. Abdou, M. T. Omar and M. E. Haiba. "Synthesis of some new 4-methylquinolines of possible biological activity", Egypt, J. Pharrm Sci., 38: (1-3) 79- 86, 1997. 16. M. M. Kamel, O. A. Fathalla, W. A. M. Abdou and M. E. Haiba. "New tetrahydronaphthyl pyridones of possible analgesic activity ", Proceeding of the Pakistan Academy of Science, 34: (1) 7-11, 1997. 15. H. H. Fahmy, E. M. M. Kassem, W. A. M. Abdou and S. A. Mahmud. "Synthesis of some new indol derivatives of possible antimicrobial activity", Egypt, J. pharm. Sci., 38: (1-3) 13-22, 1997. 14. M. A. Salama, G. H. Sayed, W. A. M. Abdou, A. S. Maghraby and E. M. Flefil. . "Synthesis and immunological studies of some new substituted tetrahydronaphthalene on Biomphalaria Alexandrina snail", Bull. Fac. Pharm. Cairo Univ., 35: (1) 65-71 1996. 13. M. Y. Ebeid, O. A. Fathalla, M. I. El-Zahar, M. M. Kamel, W. A. M. Abdou and M. M. Anwar. "New tetralyl thiazoles the anti- HIV and anticancer screening of 3-{4- [6(1,2,3,4-tetrahydronaphthyl)-thiazol-2-yl-2-(p-chlorophenyl)-thiazolidin-4-one", Bull. Fac. Pharm. Cairo Univ., 34: (2) 125-135, 1996.

16 12. M. M. Kamel, M. T. Omar, W. A. M. Abdou and N. S. Ismail. . "Synthesis of some new 1,8-naphthyridine Mannich bases and sulfonamides of expected antimicrobial activity", Al-Azhar Bull. Sci., 7: 101- 110, 1996. 11. M. M. Kamel, H. H. Fahmy and W. A. M. Abdou. "Synthesis of subustituted tetralins of possible molluscicidal activity", Egypt. J. Chem., 39: (6) 573 -580, 1996. 10. M. M. Kamel, E. M. M. Kassem, H. H. Fahmy and W. A. M. Abdou. "Synthesis and preliminary antimicrobial screening of new tetrahydronaphthyl heterocycles", Egypt. J. Chem., 39: (3) 271-280, 1996. 9. H. H. Fahmy, W. A. M. Abdou and W. Iraky. "Synthesis of some new pyrazolones as potent anti-inflammatory agents", Bull. Fac. Pharm. Cairo Univ., 33: (3) 85-91, 1995. 8. M. M. Kamel, O. A. Fathalla, M. Rizk, E. M. M. Kassem and W. A. M. Abdou "Synthesis and effect of some new 2(1H) pyrimidinthiones on Biomphalaria Alexandrina snail enzymes", Egypt. J. pharm. Sci., 35 : 355, 1994. 7. E. M. M. Kassem, S. El Difrawy, O. A. Fathalla, A. El Ansary and W. A. M. Abdou "Synthesis of some new thiazolidineamide and pyrazolidines of possible inhibitory effect on Biomphalaria Alexandrina snail enzymatic activities", Bull. J. Bilh., (1-2): 171, 1993. 6. K. Z. Gadalla, M. T. Omar, M. M. Kamel and W. A. M. Abdou. "Synthesis of some substituted pyrimidines of possible molluscicidal activity", Bull. NRC, Egypt, 18: (2) 119- 123, 1993. 5. M. Y. Ebeid, A. El Ansary, M. M. Kamel, E. M. M. Kassem and W. A. M. Abdou and N. zayed. "Synthesis and effect of new tetrahydronapthyl- ∆2 pyrazolines on Carbohydrate metabolism in bilharzia snails", Bull. Fac. Pharm. Cairo Univ.,30: (3) 293, 1992.

4. M. Y. Ebeid, M. M. Kamel, N. Abdalla, E. M. M. Kassem and W. A. M. Abdou. "New tetrahydronaphthyl pyridones of possible analgesic activity", Bull. Fac. Pharm. Cairo Univ., 29: (3) 15, 1991. 3. M. Y. Ebeid, M. M. Kamel, Z. M. Nofal, K. Z. Gadalla and W. A. M. Abdou. "Synthesis of some new p- (cinnamoyl anilino) - pyrimidine and other related Products of possible antischistosomal activity", Egypt. J. Pharrm Sci., 32: (1-2) 381- 387, 1991. 2. M. M. Kamel, W. A. M. Abdou, K. M. Amin, E. M. M. Kassem and A. M. Soliman "New pyrimidine – Mannich bases of possible schistosomicidal activity", Die. Pharmazie, 45: 139-140, 1990. 1. Nabih, A.Z. Abdel- Hamid, M. M. Kamel and W. A. M. Abdou. "Effect of some pyrimidine antimetabolites on nucleic acid content in fresh water snails, specific intermediate host of schistosomiasis", Egypt. J. Bilh., 11: (1-2) 122 – 164, 1989.

CONFERENCES

1. Member of the Scientific Committee and Chairman of a Scientific Session at the 4th International Pharma Conference 2020: 18th – 19th November (virtual conference) Faculty of Pharmacy, Helwan University, Cairo, Egypt. 2. Attendance of The First International Conference for Africa Studies, Sustainable Development for Africa We Want ICAS 2019: December 9-11 at Helwan University, Egypt. 3. Member of the Scientific Committee and Chairman of a Scientific Session at the 3rd International Pharma Conference 2019: 11th – 12th September Faculty of Pharmacy, Helwan University, Egypt, at Tolip El-Narges, New Cairo, Cairo, Egypt. 4. Member of the Scientific Committee and Chairman of a Scientific Session at the 2nd International Pharma Conference 2018: 11th – 12th September Faculty of Pharmacy, Helwan University, Egypt, at Air Defense, Nasr City, Cairo, Egypt. 5. Attendance of 1st International Conference of Egyptian Society of Food Safety, 2018: February 15-18 at Sharm El- Sheikh, Egypt. 6. Member of the Scientific Committee at 1st International Pharma Conference (1st IPC), 2017: 1th - 2nd October Faculty of Pharmacy, Helwan University, Egypt, at Tulip Hotel, Zahra Nasr City, Cairo, Egypt. 7. Tamer Nasr, Mahmoud Youns, Samir Bondock, Wafaa Zaghary. "Synthesis and biological evaluation of new pyrazolotriazinone derivatives as antitumor agents", 6th International Chemistry Conference 2016: 8th to 10th November at King Saud University, Riyadh, Saudi Arabia. (Poster presentation) 8. Wafaa A. Zaghary, Mohammed A. Motaleb, Manal M. Anwar. "Preliminary assessment of 99mTc-salmeterol xinafoate as a potential bone-imaging agent", Drug Discovery and Therapy World Congress 2015: will be on 22nd to 25th July 2015 at John B. Hynes Veterans Memorial Convention Center, Boston, USA. (Oral presentation and Co-chairman). 9. Mohammed A. Khedr and Wafaa A. Zaghary. "Discovery of Novel Potential Hypoglycemic agents by a Structure-Based Design Approach", 3rd Future University International Conference on Pharmaceutical Sciences, February 9-11, 2015 at Intercontinental City Stars Hotel, Nasr City, Cairo, Egypt. 10. Wafaa A. Zaghary. The Cabinet of Ministers, National Authority Assurance and Accreditation of Education Conference, Conference and Festival of Higher Education Sector: 25 May 2015 at Grand Celebration Hall, Cairo University. 11. Reem I. Al-wabli, Mohammed A. Khedr, Adnan A. Kadi, Mohammed A. Motaleb, Khalid A. Al-rashood, and Wafaa A. Zaghary. "Synthesis, molecular docking and antibacterial evaluation of various quinoline schiff bases: labeling and biodistribution of 99mTc-2-(p-hydroxybenzylidene)-1-(quinolin-4-yl) hydrazine", 6Th International Conference on Drug Discovery & Therapy February 10th – 12th, 2014, Dubai, UAE.

18 12. The 5th International Chemistry Conference, Department of Chemistry, College of Science, King Khalid University and the Saudi Chemical Society, Abha, (26-29th) April, 2014. 13. Maha S. Al Mutairi, Mohammed A. Motaleb, Nadia G. Haress and Wafaa A. Zaghary. "Biodistribution of 99mTc-2-Aminoestrone-3-Methyl Ether as a Potential Radiotracer Inflammation Imaging", Metabolomics & Systems Biology Conference. 24-26 March 2014. San Antonio, USA. 14. Reem I. Al-wabli, Mohammed A. Khedr, Rabab El Dib, Nadia G. Haress, and Wafaa A. Zaghary. "3-substituted-4-Quinolines: effect of substituents on NMR Features and the Relationship Between, Molecular Docking and Antibacterial Activity", Drug Discovery & Therapy World Congress June 16-19 2014, Boston, MA, USA. 15. Wafaa A. Zaghary. Saudi Health Conference, Riyadh International Convention and Exhibition Centre, Riyadh, Kingdom of Saudi Arabia, 12-14 May 2013. 16. M. A. Motaleb, N. M. Al-Musayeib, E. S. Al-abdullah, H. A. Shweeta, W. A. Zaghary."Synthesis and evaluation of a novel 99mTc-shikonin as a potential tumor imaging agent and in-vitro antitumor activity of shikonin dioxime", 34th EORTC- PAMM-BACR meeting, Cardiff Wales, UK. 23-26 January 2013. 17. The 2nd Saudi International Nanotechnology Conference (2SINC). King Abdul Aziz City for Science and Technology, Kingdom of Saudi Arabia, November 11 – 13, 2012. 18. Reem I. Al-wabli, M. A. Motaleb, Adnan A. Kadi , Khalid A. Al-rashood, Wafaa A. Zaghary. "Labeling and biodistribution of 99mTc-7-bromo-1,4-dihydro-4-oxo- quinolin-3- carboxylic acid complex", 3rd International Conference on Drug Discovery & Therapy. Dubai, UAE, February & 7th – 10th, 2011. 19. M. A. Motaleb, E. S. Alabdullah, W. A. Zaghary. "Synthesis, Radiochemical and Biological Characteristics of 99mTc-Quinoline Derivative Complex: A Novel Agent for Infection Imaging ", The 8th International Saudi Pharmaceutical Conference. Riyadh- Kingdom of Saudi Arabia, April 26-28, 2010. 20. The 2nd international Conference of pharmaceutical and Drug Industries Division under the Theme of “Applied Research for Drug Industry”, National Research Center, Giza – Egypt, March 7-9, 2005. 21. Al-Azhar 3rd International Conference for Pharmaceutical and Biological Sciences, Cairo - Egypt, December 16-18, 2003. 22. The First international Congress of pharmaceutical and Drug Industries Division “Towards Safe and Active Drug”, National Research Center, Giza – Egypt, March 24-26, 2003. 23. Al-Azhar 2nd International Conference for Pharmaceutical and Biological Sciences, Cairo - Egypt, December 19-21, 2001. 24. American Chemical Society Conference, October 16-20, 1999. Texas, USA. 25. International School and fifth Workshop work program, The 5th International School of Crystallography and Applications, Suez – Egypt, April 5-11, 1997. 26. M. Y. Ebeid, M. M. Kamel, F. Ragab, Z. M. Nofal, A. A. E. Ahmed, W. A. Zaghary and M. El Kady. "Synthesis of some new substituted tetrahydroacridine of possible antimicrobial activity, 14th Egyptian Chemical Society Conference, November 16-20, 1996.